Browsing by Author Young, Paul

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 20 of 236  next >
Issue DateTitleAuthor(s)Citation
2016The ability of people with intellectual disability to use inhalers - an exploratory mixed methods studyBosnic-Anticevich, Sinthia; Davis, Sharon; Durvasula, Seeta; Traini, Daniela; Young, Paul; Merhi, Diana; School of Medical Sciences: Pharmacology; Medicine; Nepean Clinical School: Medicine; School of Medical Sciences: Pharmacology; School of Medical Sciences: PharmacologyThe ability of people with intellectual disability to use inhalers - an exploratory mixed methods study, Journal of Asthma, vol.53, 1, 2016,pp 86-93
2015Acetaminophen for Fever in Critically Ill Patients with Suspected InfectionMyburgh, John; Bellomo, Rinaldo; et al, Various; Freebairn, R. C.; Hammond, Naomi; Henderson, Seton; Holliday, Mark; Mackle, Diane; Saxena, Manoj K; van Haren, Frank; Young, Paul; The George Institute for Global HealthAcetaminophen for Fever in Critically Ill Patients with Suspected Infection, The New England Journal of Medicine, vol.373, 23, 2015,pp 2215-2224
2014Across the pulmonary epithelial barrier: Integration of physicochemical properties and human cell models to study pulmonary drug formulationsHaghi, Mehra; Ong, Hui Xin; Traini, Daniela; Young, Paul; Pharmacy; Pharmacy; School of Medical Sciences: Pharmacology; School of Medical Sciences: PharmacologyAcross the pulmonary epithelial barrier: Integration of physicochemical properties and human cell models to study pulmonary drug formulations, Pharmacology & Therapeutics, vol.144, 3, 2014,pp 235-252
2011Advances in drug delivery: is triple therapy the future for the treatment of chronic obstructive pulmonary disease?Iliev, Ilian; Lallement, Arthur; Rogueda, Philippe; Salama, Rania; Traini, Daniela; Young, Paul; Pharmacy; Pharmacy; Pharmacy; Pharmacy; Pharmacy; PharmacyAdvances in drug delivery: is triple therapy the future for the treatment of chronic obstructive pulmonary disease?, Expert Opinion on Pharmacotherapy, vol.12, 12, 2011,pp 1913-1932
2008Advances in Pulmonary TherapyTraini, Daniela; Young, Paul; Edge, Stephen; Pharmacy; PharmacyAdvances in Pulmonary Therapy in Advanced Drug Formulation Design to Optimize Therapeutic Outcome, Informa Healthcare, 2008, pp. 1-51
2015Aerosol particle generation from solution-based pressurized metered dose inhalers: a technical overview of parameters that influence respiratory depositionTraini, Daniela; Young, Paul; Zhu, Bing; School of Medical Sciences: Pharmacology; School of Medical Sciences: Pharmacology; Central Clinical School: Woolcock Inst. of Medical ResearchAerosol particle generation from solution-based pressurized metered dose inhalers: a technical overview of parameters that influence respiratory deposition, Pharmaceutical Development and Technology, vol.20, 8, 2015,pp 897-910
2011Aerosol tribocharging and its relation to the deposition of Oxis Turbuhaler in the electrical next generation impactor.Hoe, Susan; Traini, Daniela; Young, Paul; Pharmacy; Pharmacy; PharmacyAerosol tribocharging and its relation to the deposition of Oxis Turbuhaler in the electrical next generation impactor., Journal of Pharmaceutical Sciences, vol.100, 12, 2011,pp 5270-5280
2009Agglomerate properties and dispersibility changes of salmeterol xinafoate from powders for inhalation after storage at high relative humidityYoung, Paul; Das, Shyamal; Larson, Ian; Stewart, Peter; School of Medical Sciences: PharmacologyAgglomerate properties and dispersibility changes of salmeterol xinafoate from powders for inhalation after storage at high relative humidity, European Journal of Pharmaceutical Sciences, vol.37, 3-4, 2009,pp 442-450
2006Agglomerate Strength and Dispersion of Salmeterol Xinafoate from Powder Mixtures for InhalationChiou, Herbert; Traini, Daniela; Young, Paul; Adi, Handoko; Larson, Ian; Stewart, Peter; Pharmacy; Pharmacy; PharmacyAgglomerate Strength and Dispersion of Salmeterol Xinafoate from Powder Mixtures for Inhalation, Pharmaceutical Research, vol.23,(11),2006,pp 2556-2565
2017Allergic environment enhances airway epithelial pro-inflammatory responses to rhinovirus infectionTraini, Daniela; Young, Paul; Chen, Yifan; Chiu, V; Do, Kimchi; Garthwaite, Linda; Herbert, Cristan; Kumar, Rakesh; School of Medical Sciences: Pharmacology; School of Medical Sciences: PharmacologyAllergic environment enhances airway epithelial pro-inflammatory responses to rhinovirus infection, Clinical Science, vol.131, 6, 2017,pp 499-509
2016Antibiotic transport across bronchial epithelial cells: Effects of molecular weight, LogP and apparent permeabilityHaghi, Mehra; Stigliani, Mariateresa; Traini, Daniela; Young, Paul; Russo, Paola; Pharmacy; Central Clinical School: Woolcock Inst. of Medical Research; School of Medical Sciences: Pharmacology; School of Medical Sciences: PharmacologyAntibiotic transport across bronchial epithelial cells: Effects of molecular weight, LogP and apparent permeability, European Journal of Pharmaceutical Sciences, vol.83, N/A, 2016,pp 45-51
2016Application of RPMI 2650 nasal cell model to a 3D printed apparatus for the testing of drug deposition and permeation of nasal productsMorgan, Lucy; Ong, Hui Xin; Traini, Daniela; Young, Paul; Pozzoli, Michele; Sonvico, Fabio; Sukkar, Maria; Concord Clinical School: Medicine; School of Medical Sciences: Pharmacology; School of Medical Sciences: Pharmacology; School of Medical Sciences: PharmacologyApplication of RPMI 2650 nasal cell model to a 3D printed apparatus for the testing of drug deposition and permeation of nasal products, European Journal of Pharmaceutics and Biopharmaceutics, vol.107, N/A, 2016,pp 223-233
2009Application of the Electrical Next Generation Impactor (eNGI) for the Electrostatic Characterization of Commercial Dry Powder Inhaler FormulationsChan, Hak-Kim (Kim); Hoe, Susan; Traini, Daniela; Young, Paul; Pharmacy; Pharmacy; Pharmacy; PharmacyApplication of the Electrical Next Generation Impactor (eNGI) for the Electrostatic Characterization of Commercial Dry Powder Inhaler Formulations, Respiratory Drug Delivery (RDD) Europe 2009, vol.N/A, 2009, pp. 433-436
2010Artesunate-clindamycin multi-kinetics and site-specific oral delivery system for antimalaric combination productsTraini, Daniela; Young, Paul; Barata, Pedro; Bettini, Ruggero; Colombo, Gaia; Colombo, Paolo; Mercuri, Salvatore; Sonvico, Fabio; Strusi, Orazio Luca; Pharmacy; PharmacyArtesunate-clindamycin multi-kinetics and site-specific oral delivery system for antimalaric combination products, Journal of Controlled Release, vol.146, N/A,pp 54-60
2015Beating Cilia Identification in Fluorescence Microscope Images for Accurate CBF MeasurementCai, Weidong Tom; Feng, Dagan; Morgan, Lucy; Ong, Hui-Xin; Song, Yang; Traini, Daniela; Young, Paul; Zhang, Fan; Buddle, Lachlan; Schl Information Technologies; Schl Information Technologies; Concord Clinical School: Medicine; School of Medical Sciences: Pharmacology; Schl Information Technologies; School of Medical Sciences: Pharmacology; School of Medical Sciences: Pharmacology; Schl Information TechnologiesBeating Cilia Identification in Fluorescence Microscope Images for Accurate CBF Measurement, Proceedings of 2015 IEEE International Conference on Image Processing (ICIP 2015), vol.1, 2015, pp. 4496-4500
2016Biological Effects of Simvastatin Formulated as pMDI on Pulmonary Epithelial CellsLee, Wing; Ong, Hui Xin; Traini, Daniela; Tulbah, Alaa; Young, Paul; Colombo, Paolo; Central Clinical School: Woolcock Inst. of Medical Research; Children's Hospital Westmead: Medicine; School of Medical Sciences: Pharmacology; Central Clinical School: Woolcock Inst. of Medical Research; School of Medical Sciences: PharmacologyBiological Effects of Simvastatin Formulated as pMDI on Pulmonary Epithelial Cells, Pharmaceutical Research, vol.33, 1, 2016,pp 92-101
2016Cell-based therapies for the treatment of idiopathic pulmonary fibrosis (IPF) diseaseGhadiri, Maliheh; Traini, Daniela; Young, Paul; Pharmacy; School of Medical Sciences: Pharmacology; School of Medical Sciences: PharmacologyCell-based therapies for the treatment of idiopathic pulmonary fibrosis (IPF) disease, Expert Opinion on Biological Therapy, vol.16, 3, 2016,pp 375-387
2008Change in Surface Energy of Lactoses After Storage at High Relative Humidity Determined by Inverse Gas ChromatographyYoung, Paul; Das, Shyamal; Larson, Ian; Stewart, Peter; PharmacyChange in Surface Energy of Lactoses After Storage at High Relative Humidity Determined by Inverse Gas Chromatography, RDD 2008 - Biological, Pharmaceutical, Clinical, and Regulatory Issues Relating to Optimized Drug Delivery by Aerosol - Book 2, vol.2,(),2008,pp 645-648
2010Characterization of P-gp Expression and Function vs. Time and Passage in the Calu-3 Air-Interface Model for Drug Delivery to the LungBebawy, Mary; Haghi, Mehra; Traini, Daniela; Young, Paul; Pharmacy; Pharmacy; Pharmacy; PharmacyCharacterization of P-gp Expression and Function vs. Time and Passage in the Calu-3 Air-Interface Model for Drug Delivery to the Lung, RDD 2010 Florida Respiratory Drug Delivery: Biological, Pharmaceutical, Clinical, and Regulatory Issues Relating to Optimized Drug Delivery by Aerosol. Book 3, vol.Book 3, 2010, pp. 875-878
2011Chronic obstructive pulmonary disease: patho-physiology, current methods of treatment and the potential for simvastatin in disease managementBebawy, Mary; Traini, Daniela; Young, Paul; Colombo, Paolo; Marin, Laura; Pharmacy; Pharmacy; PharmacyChronic obstructive pulmonary disease: patho-physiology, current methods of treatment and the potential for simvastatin in disease management, Expert Opinion on Drug Delivery, vol.8, 9, 2011,pp 1205-1220